3 results
Approved WMOWill not start
Primary: To assess the antiviral efficacy of triple combination antiviral drug (TCAD) therapy(i.e. amantadine and ribavirin co-administered with oseltamivir) compared to oseltamivirmonotherapy in immunocompromised subjects diagnosed with Influenza…
Approved WMOCompleted
In this study, plerixafor, the study drug, will be given in addition to GCSF to see if it works the same way in children as in adults.
Approved WMOWill not start
To demonstrate that Plerixafor is able to reduce the need for invasive mechanical ventilation or death in severe COVID-19 patients admitted in Intensive Care Unit (ICU)